Corticoides sistémicos en AD

Open access

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

• A.M. Drucker
• K. Eyerich
• M.S. de Bruin‐Weller
• J.P. Thyssen
• P.I. Spuls
• A.D. Irvine
• G. Girolomoni
• S. Dhar
• C. Flohr
• D.F. Murrell
• A.S. Paller
• E. Guttman‐Yassky

• British Journal of Dermatology
• Pages: 768-775
• DOI: 10.1111/bjd.15928

What's already known about this topic?

• Despite recommendations against their use in practice guidelines, systemic corticosteroids are commonly used for atopic dermatitis (AD).

What does this study add?

• The International Eczema Council reached consensus on circumstances in which systemic corticosteroids can be used for AD, including a lack of other treatment options, as a bridge to other systemic therapies or phototherapy, during acute flares in need of immediate relief, in anticipation of a major life event, or in the most severe cases.
• Clinicians should limit the use of systemic corticosteroids for severe AD to those circumstances.

Plain language summary available online

Respond to this article

• Abstract
• Full text
• PDF
• References
• Request permissions